| scholarly article | Q13442814 |
| P356 | DOI | 10.1182/BLOOD-2004-03-1203 |
| P698 | PubMed publication ID | 15319291 |
| P50 | author | Deborah J. Cook | Q28823530 |
| Jeffrey I. Weitz | Q29561411 | ||
| P2093 | author name string | Mark Loeb | |
| Charles T Esmon | |||
| Jim A Julian | |||
| Mark Crowther | |||
| Kamyar Kahnamoui | |||
| Patricia C Y Liaw | |||
| Suzanne Beaudin | |||
| Gary Ferrell | |||
| Sarah Kahnamoui | |||
| Shelley Schmidt | |||
| P433 | issue | 13 | |
| P921 | main subject | sepsis | Q183134 |
| drotrecogin alfa | Q412888 | ||
| P304 | page(s) | 3958-3964 | |
| P577 | publication date | 2004-08-19 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Patients with severe sepsis vary markedly in their ability to generate activated protein C | |
| P478 | volume | 104 |
| Q43051654 | A case report of a new pulmonary embolism occurring in a patient receiving continuous infusion of recombinant activated protein C. |
| Q37600822 | Activated Protein C Drives the Hyperfibrinolysis of Acute Traumatic Coagulopathy. |
| Q33846825 | Activated protein C action in inflammation |
| Q43292138 | Activated protein C improves the severity of severe acute pancreatitis via up-regulating the expressions of endothelial cell protein C receptor and thrombomodulin |
| Q37241529 | Activated protein C in sepsis: the promise of nonanticoagulant activated protein C. |
| Q40056621 | Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis |
| Q83940730 | Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications. [corrected] |
| Q58418431 | Activation of coagulation in bullous pemphigoid and other eosinophil-related inflammatory skin diseases |
| Q33373012 | Acute inflammation is exacerbated in mice genetically predisposed to a severe protein C deficiency |
| Q39600549 | Adenosine regulates thrombomodulin and endothelial protein C receptor expression in folliculostellate cells of the pituitary gland. |
| Q33931868 | Age-dependent vulnerability to endotoxemia is associated with reduction of anticoagulant factors activated protein C and thrombomodulin |
| Q33857610 | Biomolecular surface engineering of pancreatic islets with thrombomodulin |
| Q30434092 | Clinical review: a review and analysis of heart rate variability and the diagnosis and prognosis of infection |
| Q58418493 | Coagulation activation in autoimmune bullous diseases |
| Q91688043 | Coagulation and Skin Autoimmunity |
| Q36546261 | Critical role of activated protein C in early coagulopathy and later organ failure, infection and death in trauma patients |
| Q24810923 | Drotrecogin alfa (recombinant human activated protein C) in severe acute pancreatitis |
| Q36487830 | Early rise in circulating endothelial protein C receptor correlates with poor outcome in severe sepsis |
| Q35616018 | Effects of membrane and soluble EPCR on the hemostatic balance and endotoxemia in mice |
| Q36835719 | Emerging role of anticoagulants and fibrinolytics in the treatment of acute respiratory distress syndrome |
| Q35990619 | Endogenous platelet factor 4 stimulates activated protein C generation in vivo and improves survival after thrombin or lipopolysaccharide challenge |
| Q36228995 | Endotoxemia and sepsis mortality reduction by non-anticoagulant activated protein C. |
| Q34528902 | From evidence to clinical practice: effective implementation of therapeutic hypothermia to improve patient outcome after cardiac arrest |
| Q37354434 | Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies |
| Q82462350 | Haemostatic abnormalities in cats with naturally occurring liver diseases |
| Q24297941 | JNK-ATF-2 inhibits thrombomodulin (TM) expression by recruiting histone deacetylase4 (HDAC4) and forming a transcriptional repression complex in the TM promoter |
| Q36162324 | Laboratory evidence of disseminated intravascular coagulation is associated with a fatal outcome in children with cerebral malaria despite an absence of clinically evident thrombosis or bleeding |
| Q36423277 | Levels of protein C and activated protein C: what do they mean? |
| Q37065724 | Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children |
| Q46978249 | Mechanisms of action of recombinant human activated Protein C |
| Q36241437 | Meningococcal infections at the start of the 21st century. |
| Q36259602 | New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated). |
| Q35855295 | Novel role of the human alveolar epithelium in regulating intra-alveolar coagulation |
| Q34855284 | Overexpression of the endothelial protein C receptor is detrimental during pneumonia-derived gram-negative sepsis (Melioidosis). |
| Q37409613 | Plasma protein C levels in immunocompromised septic patients are significantly lower than immunocompetent septic patients: a prospective cohort study. |
| Q36569735 | Plasmin-dependent proteolysis of tissue factor pathway inhibitor in a mouse model of endotoxemia |
| Q36634005 | Prognostic utility and characterization of cell-free DNA in patients with severe sepsis |
| Q54548201 | Protein C -1641A/-1654C haplotype is associated with organ dysfunction and the fatal outcome of severe sepsis in Chinese Han population. |
| Q37784567 | Protein C as an early biomarker to distinguish pneumonia from sepsis |
| Q42588928 | Sepsis-associated disseminated intravascular coagulation and thromboembolic disease |
| Q35963106 | Sepsis-induced coagulation in the baboon lung is associated with decreased tissue factor pathway inhibitor. |
| Q36995847 | Sepsis: a clinical update. |
| Q52651076 | The H3 Haplotype of the EPCR Gene Determines High sEPCR Levels in Critically Ill Septic Patients. |
| Q79799902 | The effect of aprotinin on activated protein C-mediated downregulation of endogenous thrombin generation |
| Q36965217 | The endothelial protein C receptor rs867186-GG genotype is associated with increased soluble EPCR and could mediate protection against severe malaria |
| Q34060608 | The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications |
| Q37852747 | Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome |
| Q36453830 | Tissue Factor in Dermatitis Herpetiformis and Bullous Pemphigoid: Link between Immune and Coagulation System in Subepidermal Autoimmune Bullous Diseases |
| Q34999169 | Upregulated but insufficient generation of activated protein C is associated with development of multiorgan failure in severe acute pancreatitis |
| Q24676668 | Vascular endothelial growth factor is an important determinant of sepsis morbidity and mortality |
Search more.